...
首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Diagnostic performance of sensitive measurements of serum thyrotropin during severe nonthyroidal illness: their role in the diagnosis of hyperthyroidism.
【24h】

Diagnostic performance of sensitive measurements of serum thyrotropin during severe nonthyroidal illness: their role in the diagnosis of hyperthyroidism.

机译:严重非甲状腺疾病期间敏感检测血清促甲状腺素的诊断性能:它们在甲亢诊断中的作用。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Serum thyrotropin (TSH) concentrations were measured serially in 14 heart-transplant recipients (group 1) and 21 patients undergoing coronary artery bypass surgery (group 2), all without thyroid disease, and randomly in 158 patients hospitalized for various other nonthyroidal illnesses, including 144 judged euthyroid (group 3), six with increased FT4 and (or) T3 (group 4), and eight classified hypothyroid by conventional tests. The serial measurements indicated profound fluctuations. In group 1, TSH was subnormal in 21% of studies and increased in 10%. In group 2, corresponding abnormalities were found in 7% and 13%, respectively. Transiently low or high TSH tended to be associated with normal free thyroxin (FT4), prolonged subnormal TSH (greater than 1 week) with subnormal FT4. By contrast, subnormal TSH plus elevated FT4, or high TSH plus low FT4, were not encountered, making it unlikely that they occur by chance in severely ill patients who are not also hyper- or hypothyroid. In group 3, a suppressed TSH (plus borderline high FT4, T3/FT3) identified four cases of subclinical hyperthyroidism; however, another 11% of patients had subnormal and 10% had above-normal TSH, paired with normal FT4 and no evidence of thyroid disease. In group 4, suppressed TSH confirmed hyperthyroidism in five of six patients, and all in group 5 had increased TSH. We conclude that, in the hospital setting, sensitive TSH measurement can help to detect or confirm mild hyperthyroidism, but the positive predictive value of TSH alone may be as low as 35%.
机译:在14例心脏移植接受者(第1组)和21例接受冠状动脉搭桥手术的患者(第2组)中连续测量了血清促甲状腺激素(TSH)的浓度,所有患者均随机接受了158例因其他各种非甲状腺疾病而住院的患者,包括通过常规检查,有144例判断为甲状腺功能正常(第3组),有6例FT4和(或)T3增加(第4组),还有8例归为甲状腺功能减退。连续测量表明波动很大。在第1组中,在21%的研究中,TSH低于正常水平,而在10%的研究中升高。在第2组中,相应的异常分别为7%和13%。短暂的TSH过低或升高往往与正常的游离甲状腺素(FT4)有关,与正常的FT4延长的亚正常TSH时间延长(大于1周)有关。相比之下,未遇到低于正常水平的TSH加FT4升高,或高TSH加低FT4,这使得在甲状腺功能亢进或甲状腺功能减退的重病患者中不太可能偶然发生这种情况。在第3组中,TSH抑制(加上较高的FT4,T3 / FT3临界值)确定了4例亚临床甲亢。但是,另有11%的患者的TSH低于正常,而10%的患者的TSH高于正常,且FT4正常,没有甲状腺疾病的证据。在第4组中,抑制TSH的患者中有6例中有5例证实甲状腺功能亢进,而在第5组中所有患者的TSH均升高。我们得出的结论是,在医院环境中,敏感的TSH测量值可以帮助检测或确认轻度甲状腺功能亢进症,但仅TSH的阳性预测值可能低至35%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号